Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Non-Hodgkin lymphoma risk in adults living with HIV across five continents

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. No evidence of increased risk of thyroid dysfunction in well-treated people living with HIV

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Associations between serum albumin and serious non-AIDS events among people living with HIV

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A modeling study of the Danish HIV epidemic in men who have sex with men: travel, pre-exposure prophylaxis and elimination

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Non-AIDS Comorbidity in People Living with HIV Compared to Uninfected Individuals Ten Years Prior to HIV-Diagnosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Mortality and Risk of Cancer After Prophylactic Bilateral Oophorectomy in Women With a Family History of Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  • AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord
  • Niels Obel
View graph of relations

OBJECTIVE: To compare non-Hodgkin lymphoma (NHL) incidence rates in adults who started antiretroviral therapy (ART) across the Asia-Pacific, South Africa, Europe, Latin, and North America.

METHODS: We included cohort data of adults living with HIV who started ART after 1995 within the framework of the International epidemiology Databases to Evaluate AIDS (IeDEA) and the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE). We used flexible parametric survival models to compare regional NHL rates at 2 years after ART start and to identify risk factors for NHL.

RESULTS: We included 210 898 adults with 1.1 million person-years (pys) of follow-up and 1552 incident NHL cases (raw overall incidence rate 142/100 000 pys). After adjusting for age at ART start, first-line ART regimen, calendar period of ART start, and especially current CD4 cell count, NHL rates were similar across regions for most population groups. However, South African women remained at increased risk of developing NHL compared with their European counterparts [adjusted hazard ratio [aHR] 1.79, 95% CI 1.19-2.70]. In Europe, Latin, and North America, NHL risk was highest in MSM (aHR 1.30, 95% CI 1.14-1.48), followed by heterosexual men (referent), and women (aHR 0.66, 95% CI 0.57-0.78).

CONCLUSIONS: The risk of developing NHL is higher in women in South Africa than in Europe and higher in MSM compared with heterosexual men and women. Reasons for these differences remain unclear. Early ART access and regular patient monitoring to avert low CD4 cell counts remain key for NHL prevention.

Original languageEnglish
JournalAIDS (London, England)
Volume32
Issue number18
Pages (from-to)2777-2786
Number of pages10
ISSN0269-9370
DOIs
Publication statusPublished - 28 Nov 2018

ID: 56394974